Fast Site Qualification for a Phase 2 Parkinson’s Disease Study
For a recent Phase 2 Parkinson’s disease study, the Rho team went above and beyond to qualify sites as quickly as possible. The first site qualification visit (SQV) was conducted in June, and 3 months later, our team had 50 sites identified and fully qualified. This success was due to excellent coordination and communication with the sites and working with experienced, knowledgeable CRAs.
Rho is tremendous; their people put in the extra effort to get our site initiated over a weekend in order to make it easier for a subject.
Principal Investigator, clinical site